# EDGAR Filing Document

**Accession Number:** 0001855175
**File Stem:** 0001628280-26-028895
**Filing Date:** 2026-4
**Character Count:** 2246
**Document Hash:** ada2121db1058e4062ed5576f85d7d7d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-26-028895.hdr.sgml**: 20260430

**ACCESSION NUMBER**: 0001628280-26-028895

**CONFORMED SUBMISSION TYPE**: DEFA14A

**PUBLIC DOCUMENT COUNT**: 3

**FILED AS OF DATE**: 20260430

**DATE AS OF CHANGE**: 20260430

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Contineum Therapeutics, Inc.
- **CENTRAL INDEX KEY:** 0001855175
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 271467257
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** DEFA14A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42001
- **FILM NUMBER:** 26925416

**BUSINESS ADDRESS:**
- **STREET 1:** 3565 GENERAL ATOMICS COURT, SUITE 200
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92121
- **BUSINESS PHONE:** (858) 333-5280

**MAIL ADDRESS:**
- **STREET 1:** 3565 GENERAL ATOMICS COURT, SUITE 200
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92121

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Pipeline Therapeutics, Inc.
- **DATE OF NAME CHANGE:** 20210405

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**SCHEDULE 14A**

Proxy Statement Pursuant to Section 14(a) of

the Securities Exchange Act of 1934 (Amendment No.)

---

| |
|:---|
| Filed by the Registrant ☒ |
| Filed by a Party other than the Registrant ☐ |
| Check the appropriate box: |

---

☐ Preliminary Proxy Statement

☐ **Confidential, for Use of the Commission Only (as permitted by Rule 14a**-**6(e)(2))**

☐ Definitive Proxy Statement

☒ Definitive Additional Materials

☐ Soliciting Material under §240.14a-12

---

| |
|:---|
| **Contineum Therapeutics, Inc.** |
| (Name of Registrant as Specified in its Charter) |
| (Name of Person(s) Filing Proxy Statement, if other than the Registrant) |
| Payment of Filing Fee (Check the all boxes that apply): |

---

☒ No fee required.

☐ Fee paid previously with preliminary materials.

☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

------

![ctnm2026naav2_pagex1.jpg](ctnm2026naav2_pagex1.jpg)

------

![ctnm2026naav2_pagex2.jpg](ctnm2026naav2_pagex2.jpg)

<br>